Cancer-related coagulopathies (Q38214968)

31 August 2017

title

Cancer-related coagulopathies (English)

1 reference

31 August 2017

Marcel Levi

1

1 reference

31 August 2017

publication date

1 May 2014

1 reference

31 August 2017

1 reference

31 August 2017

volume

133 Suppl 2

1 reference

31 August 2017

page(s)

S70-5

1 reference

Venous thromboembolism and cancer: risks and outcomes

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Disseminated intravascular coagulation in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Thrombotic microangiopathy in the cancer patient

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Disseminated intravascular coagulation in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Mechanisms of thrombosis in cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Coagulation and cancer: biological and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Tissue factor and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Heparanase, tissue factor, and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Tumor shedding and coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Tissue factor-bearing microparticles and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Molecular basis for the relationship between thrombosis and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Interleukin 10 release during endotoxaemia in chimpanzees: role of platelet-activating factor and interleukin 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Chemotherapy enhances endothelial cell reactivity to platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Endothelium: interface between coagulation and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow trans

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Abnormalities of von Willebrand factor multimers in drug-associated thrombotic microangiopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Determination of plasma tissue factor antigen and its clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Disseminated intravascular coagulation: a disease-specific approach

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Nonbacterial thrombotic endocarditis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Coagulation disorders in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Venous thromboembolism and occult malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Fibrinolysis in metastatic cancer of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

A high rate of venous thromboembolism in a multi-institutional phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Catastrophic antiphospholipid syndrome mimicking a malignant pancreatic tumour--a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Delayed renal failure with extensive mesangiolysis following bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Thrombotic Microangiopathy and Renal Failure Associated with Antineoplastic Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Myeloproliferative neoplasms and thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Disseminated intravascular coagulation in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

Thrombosis with epsilon aminocaproic acid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

The thrombophilic state in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

The coagulopathy of acute promyelocytic leukaemia revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2814%2950012-6

7 January 2021

10.1016/S0049-3848(14)50012-6

Identifiers

DOI

1 reference

31 August 2017

1 reference